Context Therapeutics Inc. CNTX

Set alert

Price alert · CNTX

All alert types
0.20 USD +0.01 +6.82%

At close

0.21 +0.01 +3.96%

Pre-market · Nov 3, 4:30 AM ET

Bid
0.20 × 3
Ask
0.20 × 3
0.1886 Day range 0.2129
0.1886 52-week range 3.62
YTD
-86.26%
1 year
-81.30%
Open
0.19
Prev close
0.1891
Mkt cap
18.56M
Vol
1.29M
Avg vol
1.53M
EPS
-0.48
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1886
High
0.2129
Forward P/E
-3.38
Beta
2.25
Short ratio
2.79
Inst. own
76.40%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
1.79
200-d avg
1.86
1y target
7.70

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CNTX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: none

Price target (mean) 7.70 +3711.9% upside
Target (low)
4.50
Target (mean)
7.70
Target (high)
10.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CNTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.05-0.06 – -0.04-0.42+88.1%00.0%4
Next quarter-0.06-0.06 – -0.06-0.23+73.9%00.0%1
Current year-0.51-0.53 – -0.49-1.50+66.0%00.0%4
Next year-0.3025-0.37 – -0.24-0.51+40.7%00.0%5

Upgrades and downgrades

The latest rating changes

CNTX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2024D. Boral CapitalInitiated—Buy
Sep 23, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024Piper SandlerInitiated—Overweight
May 9, 2024HC Wainwright & Co.MaintainedBuyBuy
May 9, 2024Maxim GroupMaintainedBuyBuy
Mar 21, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 1, 2023HC Wainwright & Co.UpgradeNeutralBuy
Sep 11, 2023Maxim GroupInitiated—Buy
Jun 6, 2023HC Wainwright & Co.Reiterated—Neutral
Mar 23, 2023HC Wainwright & Co.DowngradeBuyNeutral
Feb 7, 2023HC Wainwright & Co.Reiterated—Buy
Feb 2, 2022HC Wainwright & Co.Initiated—Buy
Jan 24, 2022ThinkEquityInitiated—Buy